Cargando…

Late-Onset Focal Epilepsy: Electroclinical Features and Prognostic Role of Leukoaraiosis

The aim of this study was to describe the electroclinical and prognostic characteristics, and to investigate the role of leukoaraiosis in outpatients with new-onset elderly focal epilepsy aged ≥60 years, referred to a tertiary epilepsy center between 2005 and December 31, 2020. Among the 720 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Tartara, Elena, Micalizzi, Elisa, Scanziani, Sofia, Ballante, Elena, Paoletti, Matteo, Galimberti, Carlo Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919697/
https://www.ncbi.nlm.nih.gov/pubmed/35295838
http://dx.doi.org/10.3389/fneur.2022.828493
_version_ 1784668986282082304
author Tartara, Elena
Micalizzi, Elisa
Scanziani, Sofia
Ballante, Elena
Paoletti, Matteo
Galimberti, Carlo Andrea
author_facet Tartara, Elena
Micalizzi, Elisa
Scanziani, Sofia
Ballante, Elena
Paoletti, Matteo
Galimberti, Carlo Andrea
author_sort Tartara, Elena
collection PubMed
description The aim of this study was to describe the electroclinical and prognostic characteristics, and to investigate the role of leukoaraiosis in outpatients with new-onset elderly focal epilepsy aged ≥60 years, referred to a tertiary epilepsy center between 2005 and December 31, 2020. Among the 720 patients who were referred to the center, we retrospectively selected 162 consecutive outpatients, with a first referral for recent-onset focal epilepsy of unknown cause (UC) or structural cause (SC), and collected a clinical and standard-Electroencephalogram (S-EEG), 24-h ambulatory EEG (A-EEG), and neuroimaging data. We also analyzed the seizure prognosis after titration of the first antiseizure medication (ASM). One hundred and four UC and 58 SC patients, followed up for 5.8 ± 5.3 years (mean ± SD), were included. Compared with the SC group, the patients with UC showed a predominance of focal seizures with impaired awareness (51.9% of cases) and focal to bilateral tonic-clonic seizures during sleep (25%); conversely, the SC group, more frequently, had focal to bilateral tonic-clonic seizures during wakefulness (39.6%) and focal aware seizures (25.8%) (p < 0.0001). Oral or gestural automatisms were prevalent in UC epilepsy (20.2 vs. 6.9% in the SC group, p = 0.04). In UC compared to patients with SC, interictal epileptiform discharges showed a preferential temporal lobe localization (p = 0.0007), low expression on S-EEG, and marked activation during deep Non-Rapid Eye Movement (NREM) sleep (p = 0.003). An overall good treatment response was found in the whole sample, with a probability of seizure freedom of 68.9% for 1 year. The cumulative probability of seizure freedom was significantly higher in the UC compared with the SC group (p < 0.0001). The prognosis was worsened by leukoaraiosis (p = 0.012). In the late-onset focal epilepsy of unknown cause, electroclinical findings suggest a temporal lobe origin of the seizures. This group showed a better prognosis compared with the patients with structural epilepsy. Leukoaraiosis, per se, negatively impacted on seizure prognosis.
format Online
Article
Text
id pubmed-8919697
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89196972022-03-15 Late-Onset Focal Epilepsy: Electroclinical Features and Prognostic Role of Leukoaraiosis Tartara, Elena Micalizzi, Elisa Scanziani, Sofia Ballante, Elena Paoletti, Matteo Galimberti, Carlo Andrea Front Neurol Neurology The aim of this study was to describe the electroclinical and prognostic characteristics, and to investigate the role of leukoaraiosis in outpatients with new-onset elderly focal epilepsy aged ≥60 years, referred to a tertiary epilepsy center between 2005 and December 31, 2020. Among the 720 patients who were referred to the center, we retrospectively selected 162 consecutive outpatients, with a first referral for recent-onset focal epilepsy of unknown cause (UC) or structural cause (SC), and collected a clinical and standard-Electroencephalogram (S-EEG), 24-h ambulatory EEG (A-EEG), and neuroimaging data. We also analyzed the seizure prognosis after titration of the first antiseizure medication (ASM). One hundred and four UC and 58 SC patients, followed up for 5.8 ± 5.3 years (mean ± SD), were included. Compared with the SC group, the patients with UC showed a predominance of focal seizures with impaired awareness (51.9% of cases) and focal to bilateral tonic-clonic seizures during sleep (25%); conversely, the SC group, more frequently, had focal to bilateral tonic-clonic seizures during wakefulness (39.6%) and focal aware seizures (25.8%) (p < 0.0001). Oral or gestural automatisms were prevalent in UC epilepsy (20.2 vs. 6.9% in the SC group, p = 0.04). In UC compared to patients with SC, interictal epileptiform discharges showed a preferential temporal lobe localization (p = 0.0007), low expression on S-EEG, and marked activation during deep Non-Rapid Eye Movement (NREM) sleep (p = 0.003). An overall good treatment response was found in the whole sample, with a probability of seizure freedom of 68.9% for 1 year. The cumulative probability of seizure freedom was significantly higher in the UC compared with the SC group (p < 0.0001). The prognosis was worsened by leukoaraiosis (p = 0.012). In the late-onset focal epilepsy of unknown cause, electroclinical findings suggest a temporal lobe origin of the seizures. This group showed a better prognosis compared with the patients with structural epilepsy. Leukoaraiosis, per se, negatively impacted on seizure prognosis. Frontiers Media S.A. 2022-02-23 /pmc/articles/PMC8919697/ /pubmed/35295838 http://dx.doi.org/10.3389/fneur.2022.828493 Text en Copyright © 2022 Tartara, Micalizzi, Scanziani, Ballante, Paoletti and Galimberti. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Tartara, Elena
Micalizzi, Elisa
Scanziani, Sofia
Ballante, Elena
Paoletti, Matteo
Galimberti, Carlo Andrea
Late-Onset Focal Epilepsy: Electroclinical Features and Prognostic Role of Leukoaraiosis
title Late-Onset Focal Epilepsy: Electroclinical Features and Prognostic Role of Leukoaraiosis
title_full Late-Onset Focal Epilepsy: Electroclinical Features and Prognostic Role of Leukoaraiosis
title_fullStr Late-Onset Focal Epilepsy: Electroclinical Features and Prognostic Role of Leukoaraiosis
title_full_unstemmed Late-Onset Focal Epilepsy: Electroclinical Features and Prognostic Role of Leukoaraiosis
title_short Late-Onset Focal Epilepsy: Electroclinical Features and Prognostic Role of Leukoaraiosis
title_sort late-onset focal epilepsy: electroclinical features and prognostic role of leukoaraiosis
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919697/
https://www.ncbi.nlm.nih.gov/pubmed/35295838
http://dx.doi.org/10.3389/fneur.2022.828493
work_keys_str_mv AT tartaraelena lateonsetfocalepilepsyelectroclinicalfeaturesandprognosticroleofleukoaraiosis
AT micalizzielisa lateonsetfocalepilepsyelectroclinicalfeaturesandprognosticroleofleukoaraiosis
AT scanzianisofia lateonsetfocalepilepsyelectroclinicalfeaturesandprognosticroleofleukoaraiosis
AT ballanteelena lateonsetfocalepilepsyelectroclinicalfeaturesandprognosticroleofleukoaraiosis
AT paolettimatteo lateonsetfocalepilepsyelectroclinicalfeaturesandprognosticroleofleukoaraiosis
AT galimberticarloandrea lateonsetfocalepilepsyelectroclinicalfeaturesandprognosticroleofleukoaraiosis